DimplingLumpBilateralProphylacticMastectomyImmunotherapymTORInhibitorsGuaranteedRenewableInsuranceAntiemeticsHormoneReplacementTherapyPathologicResponseCachexiaKi-67RateBOCABRCAGeneAyurvedaChemotherapyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenMetastasisPhyllodesTumorEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each year5-FluorouracilCystDoxorubicinLymphoscintigraphyAdvocacyCytotoxicBiopsyDefinitiveSurgeryEstrogen/EstradiolCAMRADRadiotherapyMastectomyBevacizumabCyclophosphamideDocetaxelNeoadjuvantTherapyBreastTomosynthesisFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.ECOGScoreCapecitabineMultimodalityTherapyMastodyniaTumorGradeMRIStagingRaloxifeneAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerDoseDenseTherapyCalcificationsCo-survivorGermlineMutationLapatinibPalpationEGFRLumpectomyPagetDiseaseHormoneReceptorStatusMethotrexateTamoxifenAromataseInhibitorsCheckpointInhibitorHER-2AntibodyTherapyDown-StagingPaclitaxelAnastrozoleProgestinFISHFlowCytometryOvarianSuppressionGeneMutationFibroadenomaAdjuvantTherapyCytostaticAdenocarcinomaHerceptinBI-RADSOligometastasesTriple +/-BreastCancerPhysicalactivity mayreduce therisk of breastcancers1 in 8womenSelf-examinationApoptosisTyrosine-KinaseInhibitorWomen ages40+ shouldhave a clinicalbreast examat least yearlyPrecisionMedicineGeneticCounselingIntraductalPapillomaKappaEpsilonPARPInhibitorsGeneticPredispositionLymphNodeStatusGailModelCDK4/6InhibitorsSERMAbsoluteRiskMultifocalTumorsER+/-RelapseMegestrolAcetateFamilyHistoryWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.ChemopreventionPalbociclibMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltBreastCancerBrachytherapyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55AlopeciaIn-situCarcinomaMorpheaPI3KinaseInhibitorsAngiogenesisLCISCMFChemotherapyACChemotherapyDimplingLumpBilateralProphylacticMastectomyImmunotherapymTORInhibitorsGuaranteedRenewableInsuranceAntiemeticsHormoneReplacementTherapyPathologicResponseCachexiaKi-67RateBOCABRCAGeneAyurvedaChemotherapyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenMetastasisPhyllodesTumorEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each year5-FluorouracilCystDoxorubicinLymphoscintigraphyAdvocacyCytotoxicBiopsyDefinitiveSurgeryEstrogen/EstradiolCAMRADRadiotherapyMastectomyBevacizumabCyclophosphamideDocetaxelNeoadjuvantTherapyBreastTomosynthesisFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.ECOGScoreCapecitabineMultimodalityTherapyMastodyniaTumorGradeMRIStagingRaloxifeneAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerDoseDenseTherapyCalcificationsCo-survivorGermlineMutationLapatinibPalpationEGFRLumpectomyPagetDiseaseHormoneReceptorStatusMethotrexateTamoxifenAromataseInhibitorsCheckpointInhibitorHER-2AntibodyTherapyDown-StagingPaclitaxelAnastrozoleProgestinFISHFlowCytometryOvarianSuppressionGeneMutationFibroadenomaAdjuvantTherapyCytostaticAdenocarcinomaHerceptinBI-RADSOligometastasesTriple +/-BreastCancerPhysicalactivity mayreduce therisk of breastcancers1 in 8womenSelf-examinationApoptosisTyrosine-KinaseInhibitorWomen ages40+ shouldhave a clinicalbreast examat least yearlyPrecisionMedicineGeneticCounselingIntraductalPapillomaKappaEpsilonPARPInhibitorsGeneticPredispositionLymphNodeStatusGailModelCDK4/6InhibitorsSERMAbsoluteRiskMultifocalTumorsER+/-RelapseMegestrolAcetateFamilyHistoryWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.ChemopreventionPalbociclibMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltBreastCancerBrachytherapyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55AlopeciaIn-situCarcinomaMorpheaPI3KinaseInhibitorsAngiogenesisLCISCMFChemotherapyACChemotherapy

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
  1. Dimpling
  2. Lump
  3. Bilateral Prophylactic Mastectomy
  4. Immunotherapy
  5. mTOR Inhibitors
  6. Guaranteed Renewable Insurance
  7. Antiemetics
  8. Hormone Replacement Therapy
  9. Pathologic Response
  10. Cachexia
  11. Ki-67 Rate
  12. BOCA
  13. BRCA Gene
  14. Ayurveda
  15. Chemotherapy
  16. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  17. Metastasis
  18. Phyllodes Tumor
  19. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  20. 5-Fluorouracil
  21. Cyst
  22. Doxorubicin
  23. Lymphoscintigraphy
  24. Advocacy
  25. Cytotoxic
  26. Biopsy
  27. Definitive Surgery
  28. Estrogen/Estradiol
  29. CAM
  30. RAD
  31. Radiotherapy
  32. Mastectomy
  33. Bevacizumab
  34. Cyclophosphamide
  35. Docetaxel
  36. Neoadjuvant Therapy
  37. Breast Tomosynthesis
  38. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  39. ECOG Score
  40. Capecitabine
  41. Multimodality Therapy
  42. Mastodynia
  43. Tumor Grade
  44. MRI
  45. Staging
  46. Raloxifene
  47. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  48. Dose Dense Therapy
  49. Calcifications
  50. Co-survivor
  51. Germline Mutation
  52. Lapatinib
  53. Palpation
  54. EGFR
  55. Lumpectomy
  56. Paget Disease
  57. Hormone Receptor Status
  58. Methotrexate
  59. Tamoxifen
  60. Aromatase Inhibitors
  61. Checkpoint Inhibitor
  62. HER-2
  63. Antibody Therapy
  64. Down-Staging
  65. Paclitaxel
  66. Anastrozole
  67. Progestin
  68. FISH
  69. Flow Cytometry
  70. Ovarian Suppression
  71. Gene Mutation
  72. Fibroadenoma
  73. Adjuvant Therapy
  74. Cytostatic
  75. Adenocarcinoma
  76. Herceptin
  77. BI-RADS
  78. Oligometastases
  79. Triple +/- Breast Cancer
  80. Physical activity may reduce the risk of breast cancers
  81. 1 in 8 women
  82. Self-examination
  83. Apoptosis
  84. Tyrosine-Kinase Inhibitor
  85. Women ages 40+ should have a clinical breast exam at least yearly
  86. Precision Medicine
  87. Genetic Counseling
  88. Intraductal Papilloma
  89. Kappa Epsilon
  90. PARP Inhibitors
  91. Genetic Predisposition
  92. Lymph Node Status
  93. Gail Model
  94. CDK4/6 Inhibitors
  95. SERM
  96. Absolute Risk
  97. Multifocal Tumors
  98. ER +/-
  99. Relapse
  100. Megestrol Acetate
  101. Family History
  102. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  103. Chemoprevention
  104. Palbociclib
  105. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  106. Breast Cancer
  107. Brachytherapy
  108. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  109. Alopecia
  110. In-situ Carcinoma
  111. Morphea
  112. PI3 Kinase Inhibitors
  113. Angiogenesis
  114. LCIS
  115. CMF Chemotherapy
  116. AC Chemotherapy